Bimatoprost Implant for Glaucoma and Cataract Surgery
Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhine)
- Age
- 22 and older
- Sex
- Any
- Trial phase
- Phase 3
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 400 (estimated)
- Sponsor
- SpyGlass Pharma, Inc. · Industry
This trial is looking for people with mild to moderate glaucoma or ocular hypertension who need cataract surgery. Participants will compare a new treatment to a standard eye drop.
You may be able to join if
- I have been diagnosed with mild to moderate open-angle glaucoma
- I have been diagnosed with ocular hypertension
- I need to have my cataract removed
- I am a female of childbearing potential and have had a negative pregnancy test
- I agree to use contraception
You may not be able to join if
- I have uncontrolled systemic disease
- I have a history of incisional or refractive corneal surgery
- I have any type of glaucoma other than open-angle or ocular hypertension
- I have had incisional glaucoma surgery or intraocular injections
- I have other eye diseases or conditions
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your EligibilityThis trial is a randomized study to evaluate the Bimatoprost Implant System used in combination with the SpyGlass IOL to Timolol Ophthalmic Solution in participants with mild to moderate open-angle glaucoma or ocular hypertension undergoing cataract surgery.
Loading trial locations…